A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ALX Oncology Inc.
ALX Oncology Inc.
Pfizer
Pfizer
Merck Sharp & Dohme LLC
Pfizer
Aurigene Discovery Technologies Limited
Pheon Therapeutics
Incyte Corporation
Turning Point Therapeutics, Inc.
Alterome Therapeutics, Inc.
GlaxoSmithKline
Aesculap AG
GlaxoSmithKline
Orano Med LLC
Guardant Health, Inc.
RasCal Therapeutics, Inc.
Beijing Biotech
Xencor, Inc.
Cartography Biosciences
A2 Biotherapeutics Inc.
Arvinas Inc.
MBrace Therapeutics
New Phase Ltd.
Revolution Medicines, Inc.
GlaxoSmithKline
EXoPERT
Var2 Pharmaceuticals
Qilu Pharmaceutical Co., Ltd.
Natera, Inc.
Revolution Medicines, Inc.
Massive Bio, Inc.
Chongqing Precision Biotech Co., Ltd
Medigen Biotechnology Corporation
A2 Biotherapeutics Inc.
Epiliquid Holding, Inc
Revolution Medicines, Inc.
Mainz Biomed
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Sapience Therapeutics
Vyriad, Inc.
ADVANCED MARKER DISCOVERY S.L.
Natera, Inc.
Jiangsu Famous Medical Technology Co., Ltd.
Chongqing Precision Biotech Co., Ltd
Singlera Genomics Inc.
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd